Connection

Annamaria Colao to Human Growth Hormone

Back to Details
This is a "connection" page, showing publications Annamaria Colao has written about Human Growth Hormone.
Annamaria Colao
Connection Strength
2.764
Human Growth Hormone
  1. Cardiovascular alterations in adult GH deficiency. Best Pract Res Clin Endocrinol Metab. 2017 02; 31(1):25-34.
    View in: PubMed
    Score: 0.595
  2. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. J Clin Endocrinol Metab. 2008 Sep; 93(9):3416-24.
    View in: PubMed
    Score: 0.324
  3. Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest. 2006 Jun; 29(6):536-43.
    View in: PubMed
    Score: 0.281
  4. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab. 2001 Apr; 86(4):1551-7.
    View in: PubMed
    Score: 0.196
  5. Cardiovascular risk after cessation of growth hormone treatment in people born small for gestational age. Lancet Diabetes Endocrinol. 2017 12; 5(12):930-932.
    View in: PubMed
    Score: 0.155
  6. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors. J Endocrinol Invest. 2017 Dec; 40(12):1373-1380.
    View in: PubMed
    Score: 0.151
  7. Pegvisomant in acromegaly: an update. J Endocrinol Invest. 2017 Jun; 40(6):577-589.
    View in: PubMed
    Score: 0.147
  8. Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study. J Endocrinol Invest. 2017 Jun; 40(6):669-678.
    View in: PubMed
    Score: 0.147
  9. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017 Feb; 20(1):46-62.
    View in: PubMed
    Score: 0.147
  10. A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues. Eur J Endocrinol. 2017 Apr; 176(4):421-431.
    View in: PubMed
    Score: 0.147
  11. Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study. PLoS One. 2017; 12(1):e0170058.
    View in: PubMed
    Score: 0.147
  12. Autoimmunity as a possible cause of growth hormone deficiency. J Endocrinol Invest. 2008 Dec; 31(12):1132-4.
    View in: PubMed
    Score: 0.084
  13. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol. 2007 Dec; 157(6):701-8.
    View in: PubMed
    Score: 0.078
  14. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease. J Endocrinol Invest. 2005 Mar; 28(3):247-52.
    View in: PubMed
    Score: 0.064
  15. Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab. 1998 Mar; 83(3):775-9.
    View in: PubMed
    Score: 0.040
  16. Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary. 2017 Dec; 20(6):668-675.
    View in: PubMed
    Score: 0.039
  17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol. 2009 Jun; 46(2):85-95.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.